公司資料
National Research Corporation 股價、新聞與催化劑
- 股票代碼:
- NRC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
21.77 USD (+2.74%)
收盤價
最後更新: 2026年8月17日
441M USD
市值
股價為何變動
As of Aug 17, 2026, NRC closed up 2.74% at $21.77. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
National Research Corporation is a healthcare analytics and experience company focused on measuring and improving patient, employee, and consumer outcomes. Its business is centered on data and analytics rather than biotech.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, National Research sits in healthcare information services.
商業模式特徵
The company generates revenue through software, analytics, and subscription-based measurement tools for healthcare organizations.
生技產業定位
National Research is outside biotech and belongs to the healthcare-data layer where software adoption matters most.
未來催化劑
- National Research Corporation's catalysts are subscription renewals, healthcare-analytics demand, and whether the patient-experience platform keeps its recurring revenue profile intact. A stable renewal picture would help confirm the business is still behaving like a durable software franchise.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。